Fig. 4From: Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the “suspected CAD” cohort of the european cardiovascular magnetic resonance registryPercentage of cost reductions of the CMR + CXA strategy in comparison to the CXA + FFR and CXA-only strategies for the German, UK, Swiss, and US health care systems. 4a Cost reductions for the CMR + CXA strategy in the entire study population of 3’647 patients. 4b Cost reductions for the CMR + CXA strategy in the subgroups of patients with atypical chest pain (n = 1’786) and with typical angina (n = 582)Back to article page